Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 4/2017

06.02.2017 | Original Article

Clinical Implications of Biliary Confluence Pattern for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma Applied to Hemihepatectomy

verfasst von: Gu-wei Ji, Fei-peng Zhu, Ke Wang, Chen-yu Jiao, Zi-cheng Shao, Xiang-cheng Li

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Since biliary variations are commonly seen, our aims are to clarify these insidious variations and discuss their surgicopathologic implications for Bismuth-Corlette (BC) type IV hilar cholangiocarcinoma (HC) applied to hemihepatectomy.

Methods

Three-dimensional images of patients with distal bile duct obstruction (n = 97) and advanced HC (n = 79) were reconstructed and analyzed retrospectively. Normal biliary confluence pattern was defined as the peripheral segment IV duct (B4) joining the common trunk of segment II (B2) and segment III (B3) ducts to form the left hepatic duct (LHD) that then joined the right hepatic duct (RHD). The lengths from left and right secondary biliary ramifications to the right side of the umbilical portion of the left portal vein (Rl-L) and the cranio-ventral side of the right portal vein (Rr-R) were measured, respectively, and compared with the resectable bile duct length in HCs. Surgicopathologic findings were compared between different BC types.

Results

The resectable bile duct length in right hemihepatectomy for eradication of type IV tumors was significantly longer than the Rl-L length in normal biliary configuration (17.4 ± 1.8 and 10.3 ± 3.4 mm, respectively, p < 0.001), and type III variation (B2 joining the common trunk of B3 and B4) was the predominant configuration (53.8%). The resectable length in left hemihepatectomy for eradication of type IV tumors was comparable with the Rr-R length in RHD absent cases (15.2 ± 2.5 and 16.4 ± 2.6 mm, respectively, p = 0.177) but significantly longer than that in normal configuration (p < 0.001). The estimated length was 8.5 ± 2.0 mm in unresectable cases. There was no significant difference between type III and IV tumors, except for the rate of nodal metastasis (29.7 and 76.0%, respectively, p < 0.001).

Conclusion

Hemihepatectomy might be selected for curative-intent resection of BC type IV tumors considering the advantageous biliary variations, whereas anatomical trisegmentectomy is recommended for the resectable bile duct length less than 10 mm. Biliary variations might result in excessive classification of BC type IV but require validation on further study.
Literatur
1.
Zurück zum Zitat Nagino M. Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. J Gastroenterol 2012; 47:1165–1176.CrossRefPubMed Nagino M. Perihilar cholangiocarcinoma: a surgeon’s viewpoint on current topics. J Gastroenterol 2012; 47:1165–1176.CrossRefPubMed
2.
Zurück zum Zitat Govil S, Reddy MS, Rela M. Surgical resection techniques for locally advanced hilar cholangiocarcinoma. Langenbecks Arch Surg 2014; 399:707–716.CrossRefPubMed Govil S, Reddy MS, Rela M. Surgical resection techniques for locally advanced hilar cholangiocarcinoma. Langenbecks Arch Surg 2014; 399:707716.CrossRefPubMed
3.
Zurück zum Zitat Ito F, Cho CS, Rikkers LF, Weber SM. Hilar cholangiocarcinoma: current management. Ann Surg 2009; 250:210–218.CrossRefPubMed Ito F, Cho CS, Rikkers LF, Weber SM. Hilar cholangiocarcinoma: current management. Ann Surg 2009; 250:210218.CrossRefPubMed
4.
Zurück zum Zitat Xiang S, Lau WY, Chen XP. Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis 2015; 30:159–171.CrossRefPubMed Xiang S, Lau WY, Chen XP. Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure. Int J Colorectal Dis 2015; 30:159171.CrossRefPubMed
6.
Zurück zum Zitat Croome KP, Rosen CB, Heimbach JK, Nagorney DM. Is Liver Transplantation Appropriate for Patients with Potentially Resectable De Novo HilarCholangiocarcinoma? J Am Coll Surg 2015; 221:130–139.CrossRefPubMed Croome KP, Rosen CB, Heimbach JK, Nagorney DM. Is Liver Transplantation Appropriate for Patients with Potentially Resectable De Novo HilarCholangiocarcinoma? J Am Coll Surg 2015; 221:130139.CrossRefPubMed
7.
Zurück zum Zitat van Gulik TM, Gouma DJ. Changing perspectives in the assessment of resectability of hilar cholangiocarcinoma. Ann Surg Oncol 2007; 14:1969–1971.CrossRefPubMedPubMedCentral van Gulik TM, Gouma DJ. Changing perspectives in the assessment of resectability of hilar cholangiocarcinoma. Ann Surg Oncol 2007; 14:19691971.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Zeng N, Tao H, Fang C, Fan Y, Xiang N, Yang J, Zhu W, Liu J, Guan T, Fang C, Xiang F. Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type III hilarcholangiocarcinoma. World J Surg Oncol 2016; 14:44.CrossRefPubMedPubMedCentral Zeng N, Tao H, Fang C, Fan Y, Xiang N, Yang J, Zhu W, Liu J, Guan T, Fang C, Xiang F. Individualized preoperative planning using three-dimensional modeling for Bismuth and Corlette type III hilarcholangiocarcinoma. World J Surg Oncol 2016; 14:44.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Chaib E, Kanas AF, Galvão FH, D’Albuquerque LA. Bile duct confluence: anatomic variations and its classification. Surg Radiol Anat 2014; 36:105–109.CrossRefPubMed Chaib E, Kanas AF, Galvão FH, D’Albuquerque LA. Bile duct confluence: anatomic variations and its classification. Surg Radiol Anat 2014; 36:105109.CrossRefPubMed
10.
Zurück zum Zitat Lee HY, Kim SH, Lee JM, Kim SW, Jang JY, Han JK, Choi BI. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT andcholangiography with revised criteria. Radiology 2006; 239:113–121.CrossRefPubMed Lee HY, Kim SH, Lee JM, Kim SW, Jang JY, Han JK, Choi BI. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT andcholangiography with revised criteria. Radiology 2006; 239:113121.CrossRefPubMed
11.
Zurück zum Zitat Kawarada Y, Das BC, Onishi H, Taoka H, Gadzijev EM, Ravnik D, Tabata M, Isaji S. Surgical anatomy of the bile duct branches of the medial segment (B4) of the liver in relation to hilar carcinoma. J Hepatobiliary Pancreat Surg 2000; 7:480–485.CrossRefPubMed Kawarada Y, Das BC, Onishi H, Taoka H, Gadzijev EM, Ravnik D, Tabata M, Isaji S. Surgical anatomy of the bile duct branches of the medial segment (B4) of the liver in relation to hilar carcinoma. J Hepatobiliary Pancreat Surg 2000; 7:480485.CrossRefPubMed
12.
Zurück zum Zitat Endo I, Matsuyama R, Mori R, Taniguchi K, Kumamoto T, Takeda K, Tanaka K, Köhn A, Schenk A. Imaging and surgical planning for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2014; 21:525–532.CrossRefPubMed Endo I, Matsuyama R, Mori R, Taniguchi K, Kumamoto T, Takeda K, Tanaka K, Köhn A, Schenk A. Imaging and surgical planning for perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2014; 21:525532.CrossRefPubMed
13.
Zurück zum Zitat Hirose T, Igami T, Ebata T, Yokoyama Y, Sugawara G, Mizuno T, Mori K, Ando M, Nagino M. Surgical and Radiological Studies on the Length of the Hepatic Ducts. World J Surg 2015; 39:2983–2989.CrossRefPubMed Hirose T, Igami T, Ebata T, Yokoyama Y, Sugawara G, Mizuno T, Mori K, Ando M, Nagino M. Surgical and Radiological Studies on the Length of the Hepatic Ducts. World J Surg 2015; 39:29832989.CrossRefPubMed
14.
Zurück zum Zitat Endo I, Shimada H, Sugita M, Fujii Y, Morioka D, Takeda K, Sugae S, Tanaka K, Togo S, Bourquain H, Peitgen HO. Role of three-dimensional imaging in operative planning for hilar cholangiocarcinoma. Surgery 2007; 142:666–675.CrossRefPubMed Endo I, Shimada H, Sugita M, Fujii Y, Morioka D, Takeda K, Sugae S, Tanaka K, Togo S, Bourquain H, Peitgen HO. Role of three-dimensional imaging in operative planning for hilar cholangiocarcinoma. Surgery 2007; 142:666675.CrossRefPubMed
15.
Zurück zum Zitat Furusawa N, Kobayashi A, Yokoyama T, Shimizu A, Motoyama H, Kanai K, Arakura N, Yamada A, Kitou Y, Miyagawa S. Biliary tract variations of the left liver with special reference to the left medial sectional bile duct in 500 patients. Am J Surg 2015; 210:351–356.CrossRefPubMed Furusawa N, Kobayashi A, Yokoyama T, Shimizu A, Motoyama H, Kanai K, Arakura N, Yamada A, Kitou Y, Miyagawa S. Biliary tract variations of the left liver with special reference to the left medial sectional bile duct in 500 patients. Am J Surg 2015; 210:351356.CrossRefPubMed
16.
Zurück zum Zitat Ohkubo M, Nagino M, Kamiya J, Yuasa N, Oda K, Arai T, Nishio H, Nimura Y. Surgical anatomy of the bile ducts at the hepatic hilum as applied to living donor liver transplantation. Ann Surg 2004; 239:82–86.CrossRefPubMedPubMedCentral Ohkubo M, Nagino M, Kamiya J, Yuasa N, Oda K, Arai T, Nishio H, Nimura Y. Surgical anatomy of the bile ducts at the hepatic hilum as applied to living donor liver transplantation. Ann Surg 2004; 239:8286.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Takeishi K, Shirabe K, Yoshida Y, Tsutsui Y, Kurihara T, Kimura K, Itoh S, Harimoto N, Yamashita YI, Ikegami T, Yoshizumi T, Nishie A, Maehara Y. Correlation between portal vein anatomy and bile duct variation in 407 living liver donors. Am J Transplant 2015; 15:155–160.CrossRefPubMed Takeishi K, Shirabe K, Yoshida Y, Tsutsui Y, Kurihara T, Kimura K, Itoh S, Harimoto N, Yamashita YI, Ikegami T, Yoshizumi T, Nishie A, Maehara Y. Correlation between portal vein anatomy and bile duct variation in 407 living liver donors. Am J Transplant 2015; 15:155160.CrossRefPubMed
18.
Zurück zum Zitat Matsumoto N, Ebata T, Yokoyama Y, Igami T, Sugawara G, Shimoyama Y, Nagino M. Role of anatomical right hepatic trisectionectomy for perihilar cholangiocarcinoma. Br J Surg 2014; 101:261–268.CrossRefPubMed Matsumoto N, Ebata T, Yokoyama Y, Igami T, Sugawara G, Shimoyama Y, Nagino M. Role of anatomical right hepatic trisectionectomy for perihilar cholangiocarcinoma. Br J Surg 2014; 101:261268.CrossRefPubMed
19.
Zurück zum Zitat Hosokawa I, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Miyazaki M. Surgical strategy for hilar cholangiocarcinoma of the left-side predominance: current role of lefttrisectionectomy. Ann Surg 2014; 259:1178–1185.CrossRefPubMed Hosokawa I, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Miyazaki M. Surgical strategy for hilar cholangiocarcinoma of the left-side predominance: current role of lefttrisectionectomy. Ann Surg 2014; 259:11781185.CrossRefPubMed
20.
Zurück zum Zitat Ebata T, Watanabe H, Ajioka Y, Oda K, Nimura Y. Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg 2002; 89:1260–1267.CrossRefPubMed Ebata T, Watanabe H, Ajioka Y, Oda K, Nimura Y. Pathological appraisal of lines of resection for bile duct carcinoma. Br J Surg 2002; 89:12601267.CrossRefPubMed
21.
Zurück zum Zitat Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, Seehofer D. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol 2012; 19:1602–1608.CrossRefPubMed Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, Seehofer D. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol 2012; 19:16021608.CrossRefPubMed
22.
Zurück zum Zitat Hu HJ, Mao H, Shrestha A, Tan YQ, Ma WJ, Yang Q, Wang JK, Cheng NS, Li FY. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China. World J Gastroenterol 2016; 22:2601–2610.CrossRefPubMedPubMedCentral Hu HJ, Mao H, Shrestha A, Tan YQ, Ma WJ, Yang Q, Wang JK, Cheng NS, Li FY. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China. World J Gastroenterol 2016; 22:2601–2610.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Ebata T, Kosuge T, Hirano S, Unno M, Yamamoto M, Miyazaki M, Kokudo N, Miyagawa S, Takada T, Nagino M. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas. Br J Surg 2014; 101:79–88.CrossRefPubMed Ebata T, Kosuge T, Hirano S, Unno M, Yamamoto M, Miyazaki M, Kokudo N, Miyagawa S, Takada T, Nagino M. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas. Br J Surg 2014; 101:79–88.CrossRefPubMed
24.
Zurück zum Zitat Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014; 399:693–705.CrossRefPubMed Popescu I, Dumitrascu T. Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making. Langenbecks Arch Surg 2014; 399:693705.CrossRefPubMed
25.
Zurück zum Zitat Higuchi R, Yamamoto M. Indications for portal vein embolization in perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2014; 21:542–549.CrossRefPubMed Higuchi R, Yamamoto M. Indications for portal vein embolization in perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2014; 21:542549.CrossRefPubMed
26.
Zurück zum Zitat Hwang S, Ko GY, Kim MH, Lee SK, Gwon DI, Ha TY, Song GW, Jung DH, Park DH, Lee SS. Preoperative Left Portal Vein Embolization for Left Liver Resection in High-Risk Hepatobiliary Malignancy Patients. World J Surg 2016; 40:2758–2765.CrossRefPubMed Hwang S, Ko GY, Kim MH, Lee SK, Gwon DI, Ha TY, Song GW, Jung DH, Park DH, Lee SS. Preoperative Left Portal Vein Embolization for Left Liver Resection in High-Risk Hepatobiliary Malignancy Patients. World J Surg 2016; 40:27582765.CrossRefPubMed
27.
Zurück zum Zitat Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) 2015; 17:691–699.CrossRefPubMedCentral Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) 2015; 17:691699.CrossRefPubMedCentral
28.
Zurück zum Zitat Izbicki JR, Tsui TY, Bohn BA, Bockhorn M. Surgical strategies in patients with advanced hilar cholangiocarcinoma (Klatskin tumor). J Gastrointest Surg 2013; 17:581–585.CrossRefPubMed Izbicki JR, Tsui TY, Bohn BA, Bockhorn M. Surgical strategies in patients with advanced hilar cholangiocarcinoma (Klatskin tumor). J Gastrointest Surg 2013; 17:581585.CrossRefPubMed
29.
Zurück zum Zitat Sotiropoulos GC, Lang H, Molmenti EP, Kaiser GM, Paul A, Broelsch CE. Partial or complete mesohepatectomy combined with resection of the hilar bifurcation in cases of Klatskin tumors: a reasonable strategy? Am J Surg 2009; 198:297–298.CrossRefPubMed Sotiropoulos GC, Lang H, Molmenti EP, Kaiser GM, Paul A, Broelsch CE. Partial or complete mesohepatectomy combined with resection of the hilar bifurcation in cases of Klatskin tumors: a reasonable strategy? Am J Surg 2009; 198:297298.CrossRefPubMed
30.
Zurück zum Zitat La Greca G, Racalbuto A, Puleo S, Licata A. Favourable anatomical variation for the resection of a Klatskin tumour. Eur J Surg Oncol 1996; 22:97–101.CrossRefPubMed La Greca G, Racalbuto A, Puleo S, Licata A. Favourable anatomical variation for the resection of a Klatskin tumour. Eur J Surg Oncol 1996; 22:97101.CrossRefPubMed
31.
Zurück zum Zitat Ni Q, Wang H, Liang X, Zhang Y, Chen W, Wang J. Successful Parenchyma-Sparing Anatomical Surgery by 3-Dimensional Reconstruction of HilarCholangiocarcinoma Combined with Anatomic Variation. J Coll Physicians Surg Pak 2016; 26:S13-15.PubMed Ni Q, Wang H, Liang X, Zhang Y, Chen W, Wang J. Successful Parenchyma-Sparing Anatomical Surgery by 3-Dimensional Reconstruction of HilarCholangiocarcinoma Combined with Anatomic Variation. J Coll Physicians Surg Pak 2016; 26:S13-15.PubMed
32.
Zurück zum Zitat Giuliante F, Ardito F, Guglielmi A, Aldrighetti L, Ferrero A, Calise F, Giulini SM, Jovine E, Breccia C, De Rose AM, Pinna AD, Nuzzo G. Association of Lymph Node Status With Survival in Patients After Liver Resection for HilarCholangiocarcinoma in an Italian Multicenter Analysis. JAMA Surg 2016; 151:916–922. Giuliante F, Ardito F, Guglielmi A, Aldrighetti L, Ferrero A, Calise F, Giulini SM, Jovine E, Breccia C, De Rose AM, Pinna AD, Nuzzo G. Association of Lymph Node Status With Survival in Patients After Liver Resection for HilarCholangiocarcinoma in an Italian Multicenter Analysis. JAMA Surg 2016; 151:916922.
Metadaten
Titel
Clinical Implications of Biliary Confluence Pattern for Bismuth-Corlette Type IV Hilar Cholangiocarcinoma Applied to Hemihepatectomy
verfasst von
Gu-wei Ji
Fei-peng Zhu
Ke Wang
Chen-yu Jiao
Zi-cheng Shao
Xiang-cheng Li
Publikationsdatum
06.02.2017
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 4/2017
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-017-3377-2

Weitere Artikel der Ausgabe 4/2017

Journal of Gastrointestinal Surgery 4/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.